Search Results - "DAZA, A. V"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? by Yao, B B, Mukherjee, S, Fan, Y, Garrison, T R, Daza, A V, Grayson, G K, Hooker, B A, Dart, M J, Sullivan, J P, Meyer, M D

    Published in British journal of pharmacology (01-09-2006)
    “…Background and purpose: The CB2 receptor has been proposed as a novel target for the treatment of pain, and CB2 receptor agonists defined in in vitro assays…”
    Get full text
    Journal Article
  2. 2

    In vitro and in vivo characterization of A‐796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models by Yao, B B, Hsieh, G C, Frost, J M, Fan, Y, Garrison, T R, Daza, A V, Grayson, G K, Zhu, C Z, Pai, M, Chandran, P, Salyers, A K, Wensink, E J, Honore, P, Sullivan, J P, Dart, M J, Meyer, M D

    Published in British journal of pharmacology (01-01-2008)
    “…Background and purpose: Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclinical pain models. AM1241 is an…”
    Get full text
    Journal Article
  3. 3

    Peripheral and central sites of action for the non‐selective cannabinoid agonist WIN 55,212‐2 in a rat model of post‐operative pain by Zhu, CZ, Mikusa, JP, Fan, Y, Hollingsworth, PR, Pai, M, Chandran, P, Daza, AV, Yao, BB, Dart, MJ, Meyer, MD, Decker, MW, Hsieh, GC, Honore, P

    Published in British journal of pharmacology (01-06-2009)
    “…Background and purpose:  Activation of cannabinoid (CB) receptors decreases nociceptive transmission in inflammatory or neuropathic pain states. However, the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Bronchial and alveolar allergen-induced anaphylaxis and the stimulation of bronchial mucociliary clearance in ragweed-sensitized dogs by Yeates, D B, Daza, A V, Mussatto, D J

    “…In allergic airways disease, we hypothesized that an acute allergen inhalation activates cells in the bronchial and alveolar regions of the lungs to initiate…”
    Get more information
    Journal Article
  7. 7
  8. 8

    In vitro and in vivo characterization of A-796260: a selective cannabinoid CB sub(2) receptor agonist exhibiting analgesic activity in rodent pain models by Yao, B B, Hsieh, G C, Frost, J M, Fan, Y, Garrison, T R, Daza, A V, Grayson, G K, Zhu, C Z, Pai, M, Chandran, P, Salyers, A K, Wensink, E J, Honore, P, Sullivan, J P

    Published in British journal of pharmacology (01-01-2008)
    “…Background and purpose: Selective cannabinoid CB sub(2) receptor agonists have demonstrated analgesic activity across multiple preclinical pain models. AMI 241…”
    Get full text
    Journal Article
  9. 9
  10. 10

    In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB sub(2) receptor? by Yao, B B, Mukherjee, S, Fan, Y, Garrison, T R, Daza, A V, Grayson, G K, Hooker, BA, Dart, MJ, Sullivan, J P, Meyer, MD

    Published in British journal of pharmacology (01-09-2006)
    “…Background and purpose: The CB sub(2) receptor has been proposed as a novel target for the treatment of pain, and CB sub(2) receptor agonists defined in in…”
    Get full text
    Journal Article
  11. 11

    Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulators by Buckner, Steven A, Milicic, Ivan, Daza, Anthony V, Coghlan, Michael J, Gopalakrishnan, Murali

    Published in British journal of pharmacology (01-02-2002)
    “…A hallmark for unstable bladder contractions is hyperexcitability and changes in the nature of spontaneous phasic activity of the bladder smooth muscle. In…”
    Get full text
    Journal Article
  12. 12

    Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function by O'Neill, A B, Buckner, S A, Brune, M E, Milicic, I, Daza, A V, Gauvin, D M, Altenbach, R J, Meyer, M D, Williams, M, Sullivan, J P, Brioni, J D

    Published in Life sciences (1973) (30-11-2001)
    “…A-204176 (N-[5-(1H-imidazol-4-y1)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide) is a potent and selective alpha1A adrenoceptor agonist that binds with…”
    Get full text
    Journal Article
  13. 13

    Functional characterization of large conductance calcium-activated K+ channel openers in bladder and vascular smooth muscle by Malysz, John, Buckner, Steven A, Daza, Anthony V, Milicic, Ivan, Perez-Medrano, Arturo, Gopalakrishnan, Murali

    “…Calcium activated K(+) channels (K(Ca) channels) are found in a variety of smooth muscle tissues, the most characterized of which are the large conductance…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes by Buckner, Steven A, Milicic, Ivan, Daza, Anthony V, Meyer, Michael D, Altenbach, Robert J, Williams, Michael, Sullivan, James P, Brioni, Jorge D

    Published in European journal of pharmacology (02-08-2002)
    “…N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide, maleate (ABT-866) is a novel alpha(1)-adrenoceptor agent with mixed pharmacological properties in vitro…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20